Generic battle seen intensifying

With many global makers' blockbuster products, such as Lipitor, Cozaar and Plavix, coming off patent, the race for the generic drug market is set to be in full force in the first half of this year.

Kiwoom Securities reported that the industry's top players, including Dong A, Hanmi, Yuhan and Chong Kun Dang, have seen a steep hike in sales on the back of their latest generic releases.

Plav...